Is HTFL or ICUI more profitable?

ICUI runs the higher net margin — HTFL at -55.82% versus ICUI at 1.39%.

Heartflow, Inc. Common Stock (HTFL) vs ICU Medical, Inc. (ICUI)

A side-by-side comparison of Heartflow, Inc. Common Stock and ICU Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HTFL

Heartflow, Inc. Common Stock

$4.41B

$51.11HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

ICUI

ICU Medical, Inc.

$3.95B

$158.16HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

Total return — HTFL vs ICUI

growth of $100 · dividends reinvested · last 1y

HTFL +81.6% (+81.6%/yr)ICUI +28.6% (+28.6%/yr)HTFL compounded faster over this window

HTFL ICUI

HTFL vs ICUI: by the numbers

•HTFL is the larger company ($4.41B vs $3.95B market cap).
•ICUI is profitable (1.39% net margin) while HTFL runs a net loss (-55.82%).

Metrics side by side

Valuation

Metric	HTFL	ICUI
P/E ratio	N/A	134.03
P/S ratio	20.78	1.83
P/B ratio	15.76	1.84
EV / EBITDA	N/A	13.55
FCF yield	N/A	3.87%

Profitability

Metric	HTFL	ICUI
Gross margin	80.08%	37.56%
Operating margin	-34.31%	5.04%
Net margin	-55.82%	1.39%
ROE	-42.32%	1.40%
ROIC	-23.69%	3.11%

Growth (annualized)

Metric	HTFL	ICUI
Revenue CAGR (5Y)	N/A	11.05%
EPS CAGR (5Y)	N/A	-62.79%
FCF CAGR (5Y)	N/A	-2.65%
Total return CAGR (5Y)	N/A	-7.18%

Frequently asked

Is HTFL or ICUI more profitable?: ICUI runs the higher net margin — HTFL at -55.82% versus ICUI at 1.39%.

Go deeper

Full HTFL analysis Full ICUI analysis Interactive comparison tool

Dig into the metrics

ICU Medical P/E ratio Heartflow, Inc. Common Stock ROE ICU Medical ROE Heartflow, Inc. Common Stock operating margin ICU Medical operating margin Heartflow, Inc. Common Stock revenue growth ICU Medical revenue growth Heartflow, Inc. Common Stock free cash flow ICU Medical free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.